Latest Hana Mining Ltd New (HNMFF) Headlines Sanluis

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest Hana Mining Ltd New (HNMFF) Headlines

Sanluis Corporacion Sets Date to Release 4th Quarter and 2013 Financial Results
Close-Up Media - Thu Feb 20, 12:19AM CST
Sanluis Corporacion, S.A.B. de C.V., a Mexican industrial company engaged in the design and manufacture of suspension and brake components for the automotive industry, announced that it will release its unaudited financial results for the fourth quarter and fiscal year ended Dec. 31, 2013, on Thursday, Feb. 27.

Dunav Resources Reports Change to the Board of Directors
Marketwire - Thu Feb 13, 2:16PM CST
Dunav Resources Ltd. (TSX VENTURE: DNV) (the "Company") reports that Jonathan Goodman and John Wakeford have resigned as directors of the Company due to other commitments. Management and the board extend their appreciation for their valuable contributions to the Company since 2011.

ICE Canadian Canola Board Margin Index Close
Commodity News Service Canada - Commodity News Service Canada, Inc. - Tue Jan 07, 3:17PM CST
The Canadian Canola Board Margin Index, as posted by ICE Futures Canada, is a formula developed by the members of the Canadian Oilseed Processors Association (COPA).

Fifth Street Senior Floating Rate Corp. Increases Quarterly Dividend by 15%
GlobeNewswire - Tue Jan 07, 3:15PM CST
Fifth Street Senior Floating Rate Corp. (NASDAQ:FSFR) ("FSFR") today announced that its Board of Directors declared a $0.23 dividend per share through March 31, 2014. The March quarterly dividend represents a 15% increase from the prior quarter's dividend of $0.20 per share.

Ewing Sarcoma Global Clinical Trials Review, H2, 2013
M2 - Fri Dec 20, 8:32AM CST
Research and Markets (http://www.researchandmarkets.com/research/2bwbbz/ewing_sarcoma) has announced the addition of the "Ewing Sarcoma Global Clinical Trials Review, H2, 2013" report to their offering. Ewing Sarcoma Global Clinical Trials Review, H2, 2013" provides data on the Ewing Sarcoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ewing Sarcoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ewing Sarcoma. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Top Companies Participating in Ewing Sarcoma Therapeutics Clinical Trials - Eli Lilly and Company - F. Hoffmann-La Roche Ltd. - Pfizer Inc. - Celgene Corporation - Amgen Inc. - Gradalis Inc. - Daiichi Sankyo Company, Limited - BioMarin Pharmaceutical Inc. Clinical Trial Overview of Top Institutes / Government - National Cancer Institute - Children's Oncology Group - Memorial Sloan Kettering Cancer Center - St. Jude Children's Research Hospital, Inc. - Stanford University - The University of Texas M. D. Anderson Cancer Center - Massachusetts General Hospital - University of Louisville - Dana-Farber Cancer Institute, Inc. - Children's Memorial Hospital For more information visit http://www.researchandmarkets.com/research/2b...ng_sarcoma

Hana Mining Ltd New (HNMFF) Stock Research Links

HNMFF Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lynk Pharmaceuticals' Zemprocitinib Shines in Phase III RA Trial

Updated Category News Views 0

A Deep Dive into Lynk Pharmaceuticals' Latest Revelation Lynk Pharmaceuticals just dropped a bombshell with their latest Phase III trial results for zemprocitinib. This selective JAK1 inhibitor seems to be bringing some serious game in the fight against moderate-to-severe rheumatoid arthritis (RA), especially for folks who haven't had much luck with biologics. The drug...

Continue Reading
Altitude+ and ViewLift Celebrate Record Fan Engagement

Updated Category News Views 38

Fresh Off the Bench: Altitude+ Rises Picture this: you're cruising through October, watching the leaves fall and the puck drop, and here come Altitude+ and ViewLift boasting some record numbers. This ain't your everyday puff piece — they've got concrete results to back it up. Altitude+, charging into the 2026–27 NHL and NBA seasons, isn't just surviving; they're...

Continue Reading
HPV Vaccine Innovations and Global Collaboration at IPVS 2026

Updated Category News Views 24

Listening and Learning on the Global Stage Stepping into IPVS 2026 felt like entering a melting pot of shared goals and renewed hope against HPV and cervical cancer. IX, strutting in with its sleeves rolled up, embodied the spirit of 'Together Against HPV' and didn’t shy away from showing its commitment to the cause. It wasn’t just about making noise; it was about...

Continue Reading
Icahn Enterprises Set for Q3 Earnings Review

Updated Category News Views 38

Icahn Enterprises Prepares for Third Quarter Insights There's something about quarterly earnings calls that gets the adrenaline pumping for investors, especially when it's about a giant like Icahn Enterprises L.P. We're talking a behemoth that wrestles in everything from energy to food packaging. If you're not eyeing this already, you probably should be. On November 3,...

Continue Reading
AvePoint Joins S&P SmallCap 600, Replacing LXP

Updated Category News Views 0

Shifting Scenes in the SmallCap Index Wall Street always throws a curveball right when you think you've seen it all. This time, it's AvePoint Inc. (NASD: AVPT) making waves as it steps into the S&P SmallCap 600 ring come November 2. Booting out LXP Industrial Trust (NYSE: LXP), this whole shuffle's coming down because those guys over at Brookfield Asset Management Ltd....

Continue Reading
Advanced Process Solutions Reshuffles Leadership Amid Growth

Updated Category News Views 131

Clint Johnson Ascends as VP Amidst Strategic Moves Clint Johnson's climb to Vice President of Services and Operations at Advanced Process Solutions (APS) ain't just routine corporate ladder gymnastics—it's a sign of shifting tides. Slapping your buddy’s back after years in the trenches, that kind of camaraderie translates into momentum. The precision manufacturing...

Continue Reading
San Simeon Estate Unveils New Paso Robles Tasting Room

Updated Category News Views 48

A New Chapter in Paso Robles Alright, it looks like the Riboli family is rolling out the red carpet at their fresh digs in Paso Robles, and it's more than just your average tasting room fluff. Nestled in the Willow Creek District, this isn't some ramshackle outpost—they're mixing wine tradition with a dollop of Central Coast flair. For investors eyeing lifestyle and...

Continue Reading
Evaluating PT and OT Benefits: What’s Driving Outcomes?

Updated Category News Views 86

Shifting Gears: Rethinking PT and OT Benefits With an uptick in conversations around physical therapy (PT) and occupational therapy (OT) benefits, it's time for health plans and employers to step up their game. Let's face it: we're not just treating aches and pains anymore. We're dealing with the big picture here - helping folks get back to their daily grind effectively...

Continue Reading
San Diego's Iconic Nightlife Venue Revives as The Quin

Updated Category News Views 66

The ghosts of PLUXX's past are getting a new home at The Quin in San Diego. It's happening in the Gaslamp Quarter, where the familiar pulse of a party will hit the scene once again. Instead of peeling walls and the typical downtown club smell, we've got internationally acclaimed DJ Sam Feldt headlining the Halloween bash—Heaven & Hell. The Quin's Next Chapter Begins on...

Continue Reading
AI Innovation Incubator Shakes Up Shanghai's Lingang

Updated Category News Views 121

Incubator Conference Lights Up Lingang Hold onto your hats, folks! Shanghai's Lingang Center is buzzing with activity as the 'World Top-performing Incubator Conference 2026' kicks off. Taking place from October 26 to 28, this gathering isn't just another run-of-the-mill tech meet-up. Oh no, it's about redefining how we talk about innovation, incubation, and the future,...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Market Sentiment for Himax Technologies Inc. Stock

Updated Category News Views 96

Understanding Himax Technologies Inc's Stock Sentiment Himax Technologies Inc (NYSE:HIMX) has shown an interesting trend in its short interest recently. The percentage of shares sold short has increased by 8.02% since the last report. As of now, approximately 3.74 million shares are sold short, which accounts for about 2.83% of the total shares available for trading....

Continue Reading
Ant International Elevates Digital Payments with AI Innovations

Updated Category News Views 134

Ant International Enhances Digital Payment Solutions Ant International, a key player in the global digital payment and financial technology sphere, has outlined a transformative journey through 2024 with significant advancements across its four primary sectors: Alipay+, Antom, WorldFirst, and Embedded Finance. The company is capitalizing on growth opportunities and...

Continue Reading
BC Platforms Unveils Game-Changing AI Technology for Researchers

Updated Category News Views 256

BC Platforms Introduces BC Catalyst for Precision Medicine BC Platforms has officially launched BC Catalyst, an innovative AI-native analytics product designed to enhance precision medicine. This breakthrough technology integrates genomic and real-world data, allowing for actionable insights throughout the entire drug lifecycle. With BC Catalyst, the company aims to...

Continue Reading
Innovative AI Solutions from Standard Metrics for Investors

Updated Category News Views 130

Standard Metrics Unveils Game-Changing AI Analyst Tool Standard Metrics recently launched an exciting feature aimed at enhancing portfolio analysis for venture capital and private equity firms. This new tool, known as the AI Analyst, revolutionizes how investors interact with their portfolio data. Empowering Investors with Instant Insights The AI Analyst facilitates a...

Continue Reading
Archer Aviation Inc: Understanding Market Sentiment Shifts

Updated Category News Views 161

Understanding Archer Aviation Inc’s Short Interest Rise Archer Aviation Inc (NYSE: ACHR) has recently seen a notable increase in its short interest as a percentage of the float, rising by 9.33% since its last report. This surge translates to approximately 101.41 million shares sold short, reflecting 18.64% of the total shares available for trading. Based on current...

Continue Reading